OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 114 filers reported holding OCULAR THERAPEUTIX INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $8,920 | -18.8% | 2,000 | -42.9% | 0.01% | -25.0% |
| Q3 2023 | $10,990 | -39.1% | 3,500 | 0.0% | 0.01% | -38.5% |
| Q2 2023 | $18,060 | +100233.3% | 3,500 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $18 | +157.1% | 3,500 | +40.0% | 0.01% | +180.0% |
| Q4 2022 | $7 | -99.9% | 2,500 | 0.0% | 0.01% | -37.5% |
| Q3 2022 | $10,000 | 0.0% | 2,500 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $10,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |